Pfizer cutting expenses likely ‘manageable’ for Veeva Systems, Baird says


Veeva Systems sign near cloud-computing company focused on pharmaceutical and life sciences industry applications

Michael Vi

Cloud software company Veeva Systems (NYSE:VEEV) is likely to manage any hiccups it could see from Pfizer (NYSE:PFE) cutting its operating expenses through 2024, investment firm Baird said.

Analyst Joe Vruwink, who has an outperform rating and $242 price target on Veeva

Source link

Leave A Reply

Your email address will not be published.